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Hepatic arterial spin labelling MRI: an initial
evaluation in mice
R. Ramasawmya,b, A. E. Campbell-Washburna, J. A. Wellsa, S. P. Johnsona,b,
R. B. Pedleyb, S. Walker-Samuela*† and M. F. Lythgoea†
The development of strategies to combat hepatic disease and augment tissue regeneration has created a need for
methods to assess regional liver function. Liver perfusion imaging has the potential to fulﬁl this need, across a range
of hepatic diseases, alongside the assessment of therapeutic response. In this study, the feasibility of hepatic arterial
spin labelling (HASL) was assessed for the ﬁrst time in mice at 9.4 T, its variability and repeatability were evaluated,
and it was applied to a model of colorectal liver metastasis. Data were acquired using ﬂow-sensitive alternating
inversion recovery-arterial spin labelling (FAIR-ASL) with a Look–Locker readout, and analysed using retrospective
respiratory gating and a T1-based quantiﬁcation. This study shows that preclinical HASL is feasible and exhibits
good repeatability and reproducibility. Mean estimated liver perfusion was 2.2 ± 0.8mL/g/min (mean± standard
error, n=10), which agrees well with previous measurements using invasive approaches. Estimates of the variation
gave a within-session coefﬁcient of variation (CVWS) of 7%, a between-session coefﬁcient of variation (CVBS) of 9%
and a between-animal coefﬁcient of variation (CVA) of 15%. The within-session Bland–Altman repeatability coefﬁ-
cient (RCWS) was 18% and the between-session repeatability coefﬁcient (RCBS) was 29%. Finally, the HASL method
was applied to a mouse model of liver metastasis, in which signiﬁcantly lower mean perfusion (1.1 ± 0.5mL/g/min,
n=6) was measured within the tumours, as seen by ﬂuorescence histology. These data indicate that precise and
accurate liver perfusion estimates can be achieved using ASL techniques, and provide a platform for future studies
investigating hepatic perfusion in mouse models of disease. Copyright © 2014 John Wiley & Sons, Ltd.
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INTRODUCTION
The application of arterial spin labelling (ASL) to the liver has not
been undertaken extensively, possibly because of the liver’s
complex blood supply and respiratory-induced artefacts, and
has been restricted to a limited number of clinical investigations
(1,2). Alternative approaches, such as contrast-enhanced com-
puted tomography, Doppler ultrasound and radioactive micro-
spheres (3), have used perfusion to predict the onset of
hepatocyte dysfunction (4), monitor tumour therapy (5) and
inform on post-transplant success (6). Moreover, MRI assessment
of liver disease pathology is well suited to the longitudinal
evaluation of disease progression and therapeutic response in
experimental models (7). A non-invasive and contrast agent-free
method that could robustly measure liver perfusion would ben-
eﬁt researchers investigating a range of liver conditions, includ-
ing cirrhosis (4) and either primary or metastatic tumours (8).
Currently, dynamic contrast-enhanced (DCE)-MRI is the most
common MRI measure of liver perfusion in clinical research, in
which the pharmacokinetics of a chelated gadolinium contrast
agent are modelled (9). The vasculature of the liver is unique,
in that the portal vein delivers approximately 75% of the blood
(10), whilst the remaining 25% is drawn from the hepatic artery.
This dual supply means that the quantiﬁcation of liver blood ﬂow
can be challenging, and requires careful consideration of acqui-
sition and modelling methods. For dual input quantiﬁcation,
arterial and venous phases in the signal enhancement curve
must be separated, which can be challenging in small animal
models of disease, as a result of limited temporal resolution
(11,12), although recent clinical studies have adopted advanced
acquisition strategies to improve this (13). Moreover, the liver is
signiﬁcantly affected by respiratory motion, and the manage-
ment of the interaction of respiratory gating with the passage
of a bolus of contrast agent during arterial and portal phases
can be particularly challenging. However, some success has been
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reported in the measurement of the ratio of the arterial and ve-
nous contributions via the hepatic perfusion index, which has
been shown to be informative for a number of liver diseases (14).
Conversely, ASL-MRI is not reliant on external contrast agent
administration, thereby offering a key advantage over DCE-MRI,
and the approach taken in this study was to estimate the total
(both portal and arterial) regional delivery to the liver. ASL-MRI
has been developed preclinically and has been utilised to mea-
sure perfusion in the brain, heart and kidneys (15–17). Despite
the potential to fulﬁl the need for robust and reliable non-
invasive liver perfusion measurement, ASL has not yet been re-
ported in the liver of small animals, although a few human studies
have been published (1,2,18,19). Here, we report the feasibility of
a ﬂow-sensitive alternating inversion recovery (FAIR) (20) se-
quence in the liver, which is a form of pulsed ASL that estimates
perfusion from two T1 measurements following slice-selective
and global inversion pulses, centred on the imaging slice.
For image acquisition during inversion recovery, a segmented
Look–Locker sampling technique was implemented (21), because
of the signal-to-noise ratio (SNR) efﬁciency of the sequence and
its previous demonstration for the measurement of myocardial
perfusion in mice (22). This gradient-echo acquisition is advan-
tageous over traditional echo planar imaging readouts used in
ASL methods because of its reduced sensitivity to image arte-
facts caused by magnetic susceptibility and motion, particularly
in small animal livers. This free-breathing approach is sensitive
to image artefacts caused by motion and, although the liver is
less clearly affected by motion than the heart, its position below
the diaphragm makes it susceptible to respiratory motion. Vari-
ous strategies have therefore been investigated in this study for
the retrospective gating of hepatic ASL (HASL) data. The tech-
nique’s variability and repeatability are assessed in order to in-
form future preclinical studies of mouse liver perfusion in
models of pathology and the assessment of novel therapies.
Finally, HASL is applied to a mouse model of liver metastasis
to assess the technique’s sensitivity to hepatic disease.
MATERIALS AND METHODS
Animal models
All animal studies were conducted in accordance with the UK
Home Ofﬁce Animals Science Procedures Act (1986). Mice were
allowed to feed ad libitum. Ten female BALB/C mice, aged 6–8
weeks, were individually anaesthetised with isoﬂurane (3% in
1 L O2/min for induction) and placed in a supine position within
the bore of a 9.4-T MRI scanner (approximately 1.9% isoﬂurane in
1 L O2/min during scanning). Subject temperatures were moni-
tored and maintained using heated water pipes, and respiratory
bellows were placed below the sternum for physiological moni-
toring (SA Instruments Inc., Stony Brook, NY, USA).
The mouse model of colorectal liver metastasis was
established using an intra-splenic injection of one million
SW1222 colorectal tumour cells in six immune-compromised
MF1 nu/nu mice (23). Imaging was performed at 4weeks post-
implantation, as determined by bioluminescent imaging. Follow-
ing MRI, mice were intravenously injected (15mg/kg) with the
perfusion marker Hoechst 33342 (Cambridge Bioscience, Cam-
bridge, UK) and blood vessels were stained using the vascular
endothelial marker CD31 (Abcam, Cambridge, UK). Fluorescence
images were taken on an Axio Imager microscope (Carl Zeiss,
Oberkochen, Germany), using an AxioCam digital colour camera.
Pulse sequences
MRI was performed on a 9.4-T MRI scanner (Agilent Technolo-
gies, Santa Clara, CA, USA) with a 39-mm-diameter birdcage coil
(RAPID Biomed, Rimpar, Germany). Mice were weighed immedi-
ately before being placed into the scanner.
An axial, respiratory-gated, high-resolution, T2-weighted,
multi-slice fast spin echo sequence was used to determine a
suitable and consistent slice for HASL measurements. An axial
imaging plane was chosen to optimally image both the portal
vein and the hepatic artery for anatomical consistency between
imaging sessions. Image parameters included: ﬁeld of view
(FOV), 30 × 30mm2; matrix size, 192 × 192; TR = 1500ms;
effective TE = 19ms; three averages; 0.5-mm-thick slices which
covered the liver; imaging time, ≈15min.
A single-slice, segmented, Look–Locker FAIR sequence with a
gradient-echo readout was used to acquire HASL data (Fig. 1);
the inversion pulse was respiratory triggered and the following
Look–Locker acquisition was free breathing. Sequence parame-
ters included: 1-mm-thick slices; FOV, 25 × 25mm2; matrix size,
128 × 128; TE = 1.18ms; inversion time spacing (TILook–Locker),
110ms; repetition time between Look–Locker sampling pulses
(TRRF), 2.3ms; sampling ﬂip angle (αRF), 8°; TRI = 13 s; 50 inversion
recovery readouts; four lines per segmented acquisition with 50
sampling points. A 6-mm localised selective inversion was
followed by a global inversion, with the scan taking around
15min. An adiabatic fast-passage inversion pulse with a length
of 2ms and bandwidth of 20 kHz was used for slice-selective
and global preparations, and 500-μs Gaussian radiofrequency
pulses were used for Look–Locker excitation.
T1 and perfusion estimates
Total liver perfusion (P) maps were quantiﬁed pixel-wise using
the Belle model (16), which has been developed and demon-
strated previously for measurements in the mouse myocardium
(Equation [1]) (22). A T1-based perfusion quantiﬁcation following
Figure 1. Schematic diagram of the respiratory-triggered, Look–Locker
T1 mapping sequence with a spoiled, single-slice, gradient-echo readout.
The inversion pulse is end-expiration triggered, followed by a free-
breathing, segmented, Look–Locker sampling train. Each segmented
block is separated by TILook–Locker; each block contains four sampling
pulses with TRRF. The sequence is performed twice with differing inver-
sion slice thicknesses as part of the ﬂow-sensitive alternating inversion
recovery-arterial spin labelling (FAIR-ASL) design; a hepatic ASL (HASL)
dataset is completed in 15min.
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a FAIR-ASL preparation provides an alternative method to
measure total liver blood ﬂow to overcome the quantiﬁcation
challenges of hepatic perfusion. Any blood ﬂowing into the slice
will cause an apparent acceleration of the longitudinal relaxa-
tion, and the Look–Locker readout provides an efﬁcient method
to accurately characterise the tissue relaxation. Perfusion
estimates from this model will thus include both arterial and
portal contributions, given by the difference in slice-selective
(T1, selective) and global (T1, global) longitudinal relaxation measure-
ments, assuming a constant blood inﬂow.
P ¼ λ
T1cap
T1global
T1selective
 1
 
[1]
A blood–tissue partition coefﬁcient λ= 0.95mL/g was taken
from previously reported 85Kr gas clearance measurements
(24). T1,cap is the intravascular capillary blood longitudinal relaxa-
tion time, which has been measured in the ventricular blood
pool in the mouse heart to have a value of 1900ms at 9.4 T
(22). High (non-physiological) perfusion deriving from the major
blood vessels was removed by automatically thresholding the
perfusion values above 20mL/g/min (16), and noise-induced
negative perfusion values were set to zero. Prior to pixel-wise
T1 ﬁtting, an edge-preserving ﬁlter (25) was applied to all data.
T1 maps were generated in MATLAB (MathWorks, Natick, MA,
USA) using a non-linear least-squares algorithm.
Look–Locker saturation correction
In order to sample the longitudinal magnetisation during its
recovery following an inversion pulse, the Look–Locker
sequence applies a train of small ﬂip angle readout pulses, sepa-
rated by a ﬁxed TI. This pulse train partially saturates the tissue
signal, resulting in an apparent longitudinal relaxation time T1*
that is shorter than the true T1 time. A three-parameter ﬁt can
be applied to the saturated inversion recovery using Equation
[2]. Assuming a perfect inversion, the true T1 can be estimated
(Equation [3]) (26) using the saturated inversion efﬁciency (β)
from Equation [2]:
S ¼ S0 1 βexp TI=T1ð Þð Þ [2]
T1 ¼ T1 β  1ð Þ [3]
Data conditioning
The free-breathing Look–Locker T1 measurement resulted in
some lines of k space being acquired during inspiration and
expiration phases. In-house analysis software was written in
MATLAB to detect images in the ASL dataset that were severely
corrupted by respiratory motion. Three retrospective data condi-
tioning modes were compared: (i) no conditioning; (ii) image
rejection as a result of the acquisition of the central three lines
of k space during a breath as recorded by a digital data-logger
(Cambridge Electronic Design, Cambridge, UK) (22); (iii) image
rejection using the phase-encoded noise-based image rejection
(PENIR) algorithm.
Previous mouse myocardium ASL measurements used a
method of retrospective gating of the Look–Locker data using
physiology recordings as acquired using a digital data-logger. A
method rejecting images from T1 quantiﬁcation as a result of
the central lines of k space being acquired during respiratory
motion was reported (mode ii), and is applied in this study.
The PENIR scheme was initially developed in-house for retro-
spective gating where respiratory trace recordings for Look–
Locker FAIR perfusion imaging were not available. PENIR exploits
the presence of ‘ghost’ artefacts in the phase-encoding direction
(Fig. 2). PENIR highlights corrupted images by observing spikes
in a user-determined region of interest (ROI) from the extracor-
poreal space (Fig. 2A). From this area, the mean signal (Fig. 2B,
blue line) will be expected to spike as a result of respiratory
motion-induced ghosting. A threshold was generated from the
mean noise signal plus one standard deviation in the remaining
extracorporeal ﬁeld and was calculated every 10 TIs. When
the spikes signiﬁcantly exceeded the data-generated threshold
(red line), images acquired at these inversion times were attrib-
uted to respiratory-induced artefacts and rejected from T1 ﬁtting.
Typically, the signal within a liver parenchyma ROI is reduced as
a result of motion artefacts (ﬁlled diamonds, Fig. 2C), which leads
to an overestimation of T1 with a concomitant effect on perfu-
sion estimates. A Tukey analysis of variance (ANOVA) was
performed between the data conditioning rejection criteria in
SPSS (IBM, Armonk, NY, USA).
Repeatability and reproducibility assessment
For the repeatability and reproducibility study, 10 female Balb/C
mice were scanned under the same protocol, 1week apart. Each
protocol included a high-resolution, respiratory-gated fast spin
echo sequence, which was used to determine the location of
the porta hepatis, where both the hepatic artery and portal vein
are visible. Four consecutive HASL scans were then performed,
with the animal maintained at a constant level of anaesthesia
and temperature.
Statistical analysis
The coefﬁcient of variation (CV) (Equation [4]), a normalised
measure of the data variability given by the ratio of the standard
deviation σ to the mean μ, was used to compare measurements
of liver perfusion:
CV ¼ σ
μ
100% [4]
Three variability measures were calculated. Repeated mea-
surements within an imaging session were used to assess the
within-session CV (CVWS ± standard error). The between-session
CV (CVBS) was estimated from a comparison of index-matched
scans between week 1 and week 2 for each mouse (i.e. week
1-scan 1 with week 2-scan 1). The between-animal variation
(CVA), reﬂecting the variability between perfusion estimates in
different animals, was calculated from all ASL scans. Each coefﬁ-
cient was calculated from a region encompassing all the liver
parenchyma within the slice. The inter-animal precision was
obtained from the standard deviation of perfusion estimates
between animals.
To determine the minimum detectable change in perfusion
given by hepatic ASL, the Bland–Altman repeatability coefﬁcient
(RC) (Equation [5]) was calculated. Bland–Altman RCs correspond
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to the 95% conﬁdence interval given by two perfusion estimates.
ΔP is the difference in perfusion estimates between time points,
P is the mean perfusion and n is the sample size:
RC ¼ 1:96
P
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃX
ðΔP2Þ
n 1
s
100% [5]
RCs were calculated from the ﬁrst two scans within each ses-
sion, for each week, and averaged to produce the within-session
RCWS. The between-session RCBS was generated from averaging
the RCs of number-matched scans between the weeks for all
the animals.
RESULTS
Hepatic arterial spin labelling
Example images from the quantiﬁcation of perfusion from HASL
data are shown in Figure 3. The mean signal within a liver tissue
ROI illustrates the difference in longitudinal relaxation rates that
are observed following slice-selective (red) and global (blue) in-
version (Fig. 3A). Here, respiration-corrupted images have been
removed from the data. Example T1 maps from pixel-wise ﬁtting
of the data for slice-selective and global inversions are shown in
Figure 3B, C, respectively. From these images, mean global T1
measured in the liver was 1.36 ± 0.06 s. Fast spin echo images
with the perfusion map overlaid on the liver parenchyma, such
as those shown in Figure 3D, revealed that high, non-
physiological perfusion values are present within the major vas-
culature, as the perfusion model is not valid in these regions.
Mean liver perfusion, estimated using Equation [1] in all datasets
acquired in this study, was 2.2 ± 0.3mL/g/min (mean± standard
deviation). The blood vessels were excluded from the perfusion
estimate by an ROI drawn on the slice-selective T1 maps and,
additionally, by removing perfusion values above 20mL/g/min.
Assessment of data conditioning modes
The differences in retrospective gating on T1 mapping can be
visualised in Figure 2D: the dataset with no conditioning [mode
Figure 2. The phase-encoded noise-based image rejection (PENIR) scheme for retrospective removal of motion-corrupted data. (A) Axial image of a
mouse liver with an example user-determined region of interest (ROI) (broken line) of the extracorporeal area in the phase-encoding direction. (B) Sig-
niﬁcant increases in the mean noise signal (blue line) above a signal-generated threshold (red line) will result in image omission (shaded areas). (C)
Inversion recovery ﬁtting in a liver region will typically overestimate T1 without correction (broken line) compared with rejection (full line) because
of reduced tissue signal from corrupted images (ﬁlled diamonds). (D) A comparison of T1 maps shows that, with no correction, the respiration artefacts
may lead to unsuccessful ﬁtting and generate areas of signal dropout (arrow). With both data-logger (DL) and PENIR retrospective gating, these areas of
dropout are recovered – no signiﬁcant differences in mean T1 were measured between these two retrospective conditioning modes (t-test, p> 0.05).
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(i)] exhibits areas of signal dropout (arrow) which correspond to
data that cannot successfully be ﬁtted to the inversion proﬁle as
a result of motion artefact-induced signal deviations. The T1
maps following gating using the data-logger [DL, mode (ii)]
and PENIR [mode (iii)] successfully recover these areas, and do
not show any signiﬁcant differences between them.
Using data conditioning mode (ii), in which images with
motion-corrupted central lines of k space were rejected using
the data-logger, only 34% of the 50 readout images remained
following rejection, whereas the PENIR scheme [mode (iii)]
maintained approximately 54% of images. Data from nine of
the 10 datasets were evaluated for mode (ii), as one set of
data was unusable because of a malfunction in respiratory
trace recording. No signiﬁcant difference in perfusion esti-
mates was measured between modes (ii) and (iii). Mode (i),
no rejection, gave perfusion estimates that were non-
signiﬁcantly higher (p> 0.2, Tukey ANOVA) than the
respiratory-corrected estimates (on average by 19%), which is
consistent with the results of a previous study (22). Comparing
modes (ii) and (iii), the data-logger method would occasionally
discard data that did not display visually obvious artefacts be-
cause of an overly wide user-deﬁned gating window employed
in the physiological monitoring software. The PENIR scheme
produced a smaller uncertainty in the least-squares three-
parameter ﬁt, compared with mode (i) and (ii) results. There-
fore, in all further experiments, mode (iii) was used for data
conditioning.
Repeatability and reproducibility of liver perfusion
estimates
A signiﬁcant increase in animal mass was measured from week 1
(18.5 ± 0.6 g) to week 2 (18.9 ± 0.4 g) (p= 0.02, paired t-test).
No signiﬁcant difference in respiratory rate during scanning
was observed between weeks 1 and 2 (49 ± 8 breaths/min in
week 1 and 49± 9 breaths/min in week 2, p> 0.37). Furthermore,
no signiﬁcant correlation was measured between estimated
liver perfusion and animal weight, breathing rate or isoﬂurane
concentration, which was individually maintained at a constant
level, but varied from 1.7 to 2.2% (ﬂow rate, 1 L O2/min) across
the subjects. No inﬂuence of anaesthesia was expected, as
previous measurements did not ﬁnd a signiﬁcant change in
total liver blood ﬂow over these relatively small isoﬂurane
concentration variations (27).
The variation within each perfusion imaging session across
the cohort can be visualised in Figure 4A, and the mean ses-
sion perfusion estimates for all animals and both weeks are
shown in Table 1. Normalising each session to the ﬁrst perfu-
sion estimate, no signiﬁcant trends in perfusion were mea-
sured during the session duration. There was no signiﬁcant
difference between the ﬁrst and last perfusion estimates across
all the imaging sessions (paired t-test, p> 0.2). In addition,
there was no between-session perfusion trends observed when
comparing scan index-matched perfusion estimates between
weeks 1 and 2 (paired t-test, p> 0.4).
Coefﬁcient of variation
The CVWS value was 7 ± 1%, CVBS was 9 ± 1% and CVA was 15
± 1%. The three data conditioning modes investigated pro-
duced CVs which differed within 1%. The mean within-session
standard deviation was calculated to be ±0.4mL/g/min.
Repeatability coefﬁcients
A Bland–Altman plot showing the within-session differences, by
comparing perfusion estimates from repeated measurements
averaged over the liver, is shown in Figure 4B. The plot is not
Figure 3. Quantiﬁcation of perfusion from a hepatic arterial spin labelling (HASL) dataset. (A) The perfusion signal comes from the difference in lon-
gitudinal recovery following slice-selective (red) and global (blue) inversion. Example T1 maps acquired after a slice-selective inversion (B) and global
inversion (C); T1 values have been clipped at 2 s (mean liver global T1 = 1.36 ± 0.06 s). (D) In the resulting perfusion map, the liver parenchyma has been
overlaid on a high-resolution T2-weighted fast spin echo image. Non-physiologically high perfusion values can be seen within major blood vessels; per-
fusion values in this image have been limited at 10mL/g/min. Mean estimated liver perfusion was 2.2 ± 0.8mL/g/min (mean ± standard error, n = 10).
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suggestive of magnitude dependence in perfusion estimates
and has a mean difference of 0.01 ± 0.34mL/g/min. Between-
session Bland–Altman analysis (Fig. 4C) is also free from any
magnitude dependence and measured a mean difference of
0.01 ± 0.46mL/g/min. The Bland–Altman RC provides an esti-
mate of the percentage change required to measure a signiﬁcant
variation in a particular parameter estimate; RCWS was 18% and
RCBS was 29%.
Application to a model of liver metastasis
Finally, the HASL technique was applied to a model of colorectal
liver metastasis (Fig. 5). A T2-weighted fast spin echo image (Fig. 5A)
facilitated tumour detection, which appeared hyperintense
(example, arrow) relative to liver tissue (outlined). Furthermore,
T1 maps produced from HASL data also distinguished tumours
from surrounding liver (arrow) because of their longer relaxation
times (Fig. 5B). Segmentation of tumours was undertaken using
T1 maps estimated from slice-selective inversions, as these
provided optimal contrast between liver, tumour tissue and
vasculature. Across six animals, a signiﬁcantly lower perfusion
was measured in tumours (1.1 ± 0.5mL/g/min, mean ± standard
deviation) relative to liver tissue (2.4 ± 0.6mL/g/min, p< 0.01,
paired t-test). This 46% perfusion difference is greater than the
measured within-session variability of HASL, and can be
observed within the tumours outlined in the perfusion map
Figure 4. (A) The variability in mean liver perfusion across all 10 animals (shown in different colours). The second imaging session was 1 week later.
Across the group, no signiﬁcant trends were observed within and between the imaging sessions. Bland–Altman plots showing the within-session re-
peatability from the ﬁrst and second mean liver perfusion estimate (B) and the between-session mean perfusion repeatability from index-matched
scans (C) .The central, thick full line represents the mean difference, and the two outer lines show the ±1.96 × standard deviation. For both plots,
the mean difference measured was within the error of the technique, and no trends could be distinguished.
Table 1. Variability of liver perfusion estimates (session average± standard deviation in mL/g/min) across the 10 mice for both
weeks
Subject
Week 1 2 3 4 5 6 7 8 9 10
1 2.6 ± 0.1 2.1 ± 0.2 2.0 ± 0.2 2.2 ± 0.1 2.3 ± 0.2 2.7 ± 0.6 2.4 ± 0.3 2.6 ± 0.1 2.1 ± 0.1 2.2 ± 0.1
2 2.1 ± 0.2 2.2 ± 0.3 1.9 ± 0.1 2.3 ± 0.1 2.0 ± 0.1 2.1 ± 0.1 2.3 ± 0.1 2.8 ± 0.2 2.7 ± 0.1 2.9 ± 0.2
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shown in Figure 5C. This perfusion deﬁcit in a well-vascularised
model of colorectal liver metastasis is in agreement with ﬂuores-
cence histology (Fig. 5D). The normal-appearing liver sinusoids
are well vascularised and perfused (arrow), as shown by the
presence of CD31 staining (red) and Hoechst 33342 (blue). The
SW1222 colorectal tumour exhibits a reduced number of blood
vessels, and thus a reduced amount of perfusion.
DISCUSSION AND CONCLUSION
We have applied Look–Locker FAIR-ASL-MRI for the ﬁrst time to
measure liver perfusion in a small animal setting. We investi-
gated the reproducibility and repeatability of the technique,
within and between imaging sessions. In addition, a method of
retrospective respiratory gating (PENIR) was introduced that is
data driven, and was found to reduce the uncertainty in the
perfusion estimate. Finally, HASL was applied to a mouse model
of colorectal liver metastasis and showed a perfusion deﬁcit
within the tumours relative to the normal liver.
The mean liver perfusion measured in this study with HASL
was 2.2 ± 0.3mL/g/min, which is in good agreement with previ-
ous estimates in the literature. Microsphere measurements
in similar weight mice gave a mean total hepatic perfusion of
1.8 ± 0.3mL/g/min (3). The same study also reported a reference
perfusion in the kidneys of 5.1 ± 0.8mL/g/min, which agrees well
with the mean perfusion measured incidentally in the renal
cortex by HASL (5.3 ± 0.6mL/g/min). In addition, a previous
study of liver perfusion in mice using DCE-MRI gave a value of
2.48mL/g/min [reported as 4.96 ± 1.87mL/min (28), converted
to bulk perfusion assuming a mouse liver mass of 2 g (29)].
The majority of previous measurements of liver perfusion
using invasive techniques, which have been undertaken in
rat rather than mouse liver, report mean liver perfusions of
2.41 ± 0.50mL/g/min (85Kr clearance) (24), 1.9 ± 0.1mL/g/min
(microspheres) (30), 2.03 ± 0.13mL/g/min (indocyanine green
clearance) and 2.28 ± 0.49mL/g/min (galactose clearance) (31).
However, at least one study has compared renal perfusion
measured with ASL in both rats and mice (17), and has found
that between-species perfusion measurements did not differ
signiﬁcantly. This could conceivably also be reﬂected in liver
perfusion between species.
From the repeatability and reproducibility analysis undertaken
in this study, the largest variability was found in measurements
between animals, suggesting that subject variability was greater
than that of the technique. Global liver perfusion could be a use-
ful quantity when applied to models of cirrhosis and liver
dysfunction, in which marked changes are likely to occur (4). In
addition, parenchymal T1 has been reported to vary as a result
of ﬁbrosis development (32) and cirrhosis onset (33), which is
provided inherently by the Look–Locker FAIR-ASL acquisition.
Isoﬂurane level has been reported previously to have a
signiﬁcant inﬂuence on myocardial perfusion measurements
(34), although no such association was found in this study, which
is in agreement with previous liver studies (27). A further poten-
tial source of variability was the feeding status between animals,
as animals were allowed to feed ad libitum. The portal vein
draws blood from the intestines, and so the between-animal
variability observed may be exacerbated by differing dietary
habits between the mice. Previous behavioural studies in mice
have reported a cyclic consumption of food approximately every
24 h (35), however in this study, no trend in perfusion was corre-
lated with the time of day to suggest that an ad libitum diet may
not be an inﬂuential factor to the variability in liver perfusion.
Future studies may investigate HASL’s sensitivity to post-prandial
liver perfusion changes following a controlled diet (19).
Figure 5. Application of hepatic arterial spin labelling (HASL) to a model of liver metastasis. (A) High-resolution T2-weighted fast spin echo images
show the tumours (arrow) as hyperintense relative to the liver tissue (outlined). (B) In the corresponding slice-selective T1 map, the metastases can
be delineated by a raised T1 (2.24 ± 0.54 s) relative to liver tissue. (C) Across n = 6 mice, a signiﬁcant reduction in perfusion (outlined) was measured
within the metastases (1.1 ± 0.5mL/g/min, mean ± standard deviation) relative to the liver tissue. This difference in perfusion measured by HASL was
conﬁrmed by histology. (D) The ﬂuorescence image shows a section of normal liver containing sinusoid vessels (arrow), demarcated from an adjacent
SW1222 colorectal liver metastasis (star) by a large reduction in the presence of blood vessels. Vascular structures are shown in red (anti-CD31 antibody)
and perfusion in blue (by the injected marker Hoechst 33342).
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Our approach also allowed us to measure much lower perfu-
sion values in a mouse model of liver metastasis, which provides
good evidence for the application of HASL to liver pathology. A
limitation of the tumour perfusion quantiﬁcation is that it utilised
the liver’s blood–tissue partition coefﬁcient; however, previous
ASL methods assumed a λT value of unity (36). However, this will
only induce a 5% difference in the perfusion estimate, and there-
fore would not affect the signiﬁcant differences measured be-
tween metastases and liver tissue. A measurable level of
perfusion within these neoplasms will facilitate perfusion-based
determination of the efﬁcacy of vascular targeting therapy (23).
A limitation of this technique is that the readout was single
slice. To provide greater coverage of the liver, the pulse
sequence proposed here could be adapted to acquire multiple
slices without impacting the total imaging time, but would
require quantiﬁcation methods that account for slice-variant in-
ﬂow effects (37). The implemented FAIR-ASL preparation and
T1-based quantiﬁcation are attractive because of their estimation
of the total liver blood ﬂow (i.e. both portal venous and arterial)
independent from modelled parameters, such as the arterial
transit time. However, the perfusion contributions of the hepatic
artery and portal vein may be separated using a pseudo-
continuous ASL (38) preparation which can distinguish the blood
contributions by independently positioning the tagging plane
on the descending aorta and portal vein (19). The ratio of arterial
to venous perfusion, the hepatic perfusion index, has been used
to stage liver tumours (39). However, such a technique is not
straightforward to implement in mice because of their small
anatomy, and the tagging efﬁciency may be reduced as a result
of respiratory and cardiac motion.
The intrinsic low-perfusion SNR of ASL experiments leads to
the majority of methods employing an efﬁcient readout, such
as echo planar imaging. However, such techniques can be partic-
ularly challenging in the mouse liver as the surrounding abdom-
inal fat and air cavities in the stomach and lungs can make
imaging prone to distortion and signal dropout. Hence, a
gradient-echo acquisition was used here and a Look–Locker
readout was applied to increase the efﬁciency of the HASL
dataset. Although the low sampling ﬂip angle used in a Look–
Locker scheme can result in low-SNR images, the large number
of TIs acquired improves the T1 estimation, but still may lead to
noise within the perfusion maps. In an alternative set-up, the
SNR may be improved using a surface receiver coil, although
we found a suboptimal coverage of the liver using such an
arrangement.
Currently, DCE-MRI is used more extensively than ASL in the
assessment of both liver and tumour perfusion. However, an
advantage of ASL over DCE-MRI is the ability to acquire data
longitudinally without the need to wait for a contrast agent to
clear, which would be particularly advantageous when assessing
physiological changes across short timescales (such as assessing
the acute response to treatment). Equally, removing the need to
perform cannulation of a vein in small animals would be a key
advantage of ASL over DCE-MRI. However, a comparison of the
relative accuracy and precision associated with each approach
would need to be performed.
HASL has good potential for clinical translation, and prelimi-
nary evaluation in humans has returned encouraging results
(2,18). As such, this methodology offers great promise in the
diagnosis and assessment of response to therapy in a number
of hepatic diseases, such as cirrhosis and metastasis, in both
the preclinical and clinical environments.
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